← Back to Search

Pain Management Techniques for ACL Surgery

N/A
Waitlist Available
Led By Cassandra Lee, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18 and 45 years old
Clinical and/or advanced imaging confirmation of ACL tear of which reconstructive surgery is recommended and accepted
Must not have
Non-English-speaking patients
Inflammatory arthritis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks post-op
Awards & highlights
No Placebo-Only Group

Summary

This trial compares pain control methods for ACL surgery patients, using either a nerve block or oral medications. It aims to see if both methods provide similar pain relief and recovery outcomes. The study will also assess the cost-effectiveness and patient flow logistics of each method.

Who is the study for?
This trial is for adults aged 18-45 who have confirmed ACL tears and are recommended to undergo reconstructive surgery. It's not suitable for those unable to consent, pregnant women, individuals with inflammatory arthritis, non-English speakers, anyone with prior knee surgeries, or prisoners.
What is being tested?
The study compares standard pain management techniques during ACL reconstruction surgery. Specifically, it looks at the effectiveness of an adductor canal nerve block using Ropivacaine injection versus no nerve block in controlling pain and improving functional outcomes post-surgery.
What are the potential side effects?
Potential side effects may include discomfort at the injection site, numbness in the leg due to the nerve block, possible allergic reactions to Ropivacaine including itching or rash, and less commonly complications related to nerve blocks such as infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 45 years old.
Select...
My ACL tear is confirmed by tests and I need surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I have inflammatory arthritis.
Select...
I am under 18 years old.
Select...
I have not had surgery on either of my knees.
Select...
I am unable to give consent for medical procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Immediate Post-op Pain Score
Opioid Use
Secondary study objectives
Intermediate-term Knee Function
Long-term Knee Function
Post-anaesthesia care unit (PACU) Time
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Adductor Canal Nerve BlockExperimental Treatment2 Interventions
Participant will receive an adductor canal nerve block via 15 mL 0.5% ropivacaine injection prior to OR for ACL reconstruction. Participant will receive pre-op oral medications.
Group II: No Nerve BlockActive Control1 Intervention
Participant will receive pre-op oral medications but no nerve block prior to OR for ACL reconstruction.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ropivacaine injection
2012
Completed Phase 4
~510
Adductor Canal Nerve Block
2016
Completed Phase 4
~210

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Anterior Cruciate Ligament (ACL) rupture include surgical reconstruction, physical therapy, and nerve blocks. Surgical reconstruction involves replacing the torn ligament with a graft, which helps restore knee stability and function. Physical therapy focuses on strengthening the muscles around the knee and improving range of motion, which is crucial for recovery and preventing further injury. Nerve blocks, such as local anesthetic nerve blocks, work by temporarily blocking nerve transmission to reduce pain during and after surgery. This is particularly important for ACL rupture patients as it can significantly improve pain management, enhance postoperative recovery, and facilitate early mobilization, which is essential for successful rehabilitation.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
943 Previous Clinical Trials
4,755,621 Total Patients Enrolled
Cassandra Lee, MDPrincipal InvestigatorUC-Davis Health

Media Library

Adductor Canal Nerve Block Clinical Trial Eligibility Overview. Trial Name: NCT03365908 — N/A
Anterior Cruciate Ligament Rupture Research Study Groups: Adductor Canal Nerve Block, No Nerve Block
Anterior Cruciate Ligament Rupture Clinical Trial 2023: Adductor Canal Nerve Block Highlights & Side Effects. Trial Name: NCT03365908 — N/A
Adductor Canal Nerve Block 2023 Treatment Timeline for Medical Study. Trial Name: NCT03365908 — N/A
~5 spots leftby Jul 2025